These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 12789273)
1. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273 [TBL] [Abstract][Full Text] [Related]
2. Generation of p53 target database via integration of microarray and global p53 DNA-binding site analysis. Liu S; Mirza A; Wang L Methods Mol Biol; 2004; 281():33-54. PubMed ID: 15220520 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells. Spurgers KB; Coombes KR; Meyn RE; Gold DL; Logothetis CJ; Johnson TJ; McDonnell TJ Oncogene; 2004 Mar; 23(9):1712-23. PubMed ID: 14647426 [TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis. Huang Y; Tan M; Gosink M; Wang KK; Sun Y Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172 [TBL] [Abstract][Full Text] [Related]
5. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Kannan K; Kaminski N; Rechavi G; Jakob-Hirsch J; Amariglio N; Givol D Oncogene; 2001 Jun; 20(26):3449-55. PubMed ID: 11423996 [TBL] [Abstract][Full Text] [Related]
6. Comparative, genome-scale transcriptional analysis of CHRF-288-11 and primary human megakaryocytic cell cultures provides novel insights into lineage-specific differentiation. Fuhrken PG; Chen C; Miller WM; Papoutsakis ET Exp Hematol; 2007 Mar; 35(3):476-489. PubMed ID: 17309828 [TBL] [Abstract][Full Text] [Related]
7. DNA microarrays identification of primary and secondary target genes regulated by p53. Kannan K; Amariglio N; Rechavi G; Jakob-Hirsch J; Kela I; Kaminski N; Getz G; Domany E; Givol D Oncogene; 2001 Apr; 20(18):2225-34. PubMed ID: 11402317 [TBL] [Abstract][Full Text] [Related]
8. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534 [TBL] [Abstract][Full Text] [Related]
9. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis. Schavolt KL; Pietenpol JA Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570 [TBL] [Abstract][Full Text] [Related]
10. Methods to study p53-repressed promoters. Dumont P; Della Pietra A; Murphy ME Methods Mol Biol; 2003; 234():111-20. PubMed ID: 12824528 [TBL] [Abstract][Full Text] [Related]
11. Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study. Daoud SS; Munson PJ; Reinhold W; Young L; Prabhu VV; Yu Q; LaRose J; Kohn KW; Weinstein JN; Pommier Y Cancer Res; 2003 Jun; 63(11):2782-93. PubMed ID: 12782583 [TBL] [Abstract][Full Text] [Related]
12. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Robles AI; Bemmels NA; Foraker AB; Harris CC Cancer Res; 2001 Sep; 61(18):6660-4. PubMed ID: 11559530 [TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of p53(+/-) knockout and wild-type mice following diethylstilbestrol administration. Salleh MN; Ismail P; Abdullah AS; Taufiq-Yap YH IUBMB Life; 2004 Jul; 56(7):409-16. PubMed ID: 15545218 [TBL] [Abstract][Full Text] [Related]
14. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network. Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214 [TBL] [Abstract][Full Text] [Related]
15. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Qian H; Wang T; Naumovski L; Lopez CD; Brachmann RK Oncogene; 2002 Nov; 21(51):7901-11. PubMed ID: 12420228 [TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors. L'Espérance S; Popa I; Bachvarova M; Plante M; Patten N; Wu L; Têtu B; Bachvarov D Int J Oncol; 2006 Jul; 29(1):5-24. PubMed ID: 16773180 [TBL] [Abstract][Full Text] [Related]
17. Cascade of transcriptional induction and repression during IL-2 deprivation-induced apoptosis. Fleischer A; Duhamel M; Lopez-Fernandez LA; Muñoz M; Rebollo MP; Alvarez-Franco F; Rebollo A Immunol Lett; 2007 Sep; 112(1):9-29. PubMed ID: 17651815 [TBL] [Abstract][Full Text] [Related]
18. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis. Li C; Lin M; Liu J Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928 [TBL] [Abstract][Full Text] [Related]
19. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis. Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670 [TBL] [Abstract][Full Text] [Related]
20. p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression. Tang X; Molina M; Amar S Cancer Res; 2007 Feb; 67(3):1308-16. PubMed ID: 17283168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]